Skip to main content

Table 1 Clinical characteristics and outcomes of intramedullary spinal cord tumours

From: Surgical management and outcome of intramedullary spinal cord tumour

No. Age/sex Localisation Tumour extension Neurological state pre-op MMS Resection Histologic origin Surgical out come on MMS Chemo Radio-therapy Post-op follow-up (MON) Last follow-up MMS
1 46/male Cervical C3-C7 III STR ASTRO/WHO III IV Yes Yes 4 III
2 68/male Dorsal D2-D5 III TR ASTRO/WHO II III Yes Yes 5 II
3 57/female Cervical C2-C6 III TR EPEND/WHO II II No Yes 24 I
4 70/male Dorsal D6-D12 IV STR ASTRO/WHO III IV Yes Yes 7 III
5 24/female Dorsal D1-D4 III TR EPEND/WHO I II No Yes 18 I
6 32/male Conus CONUS II TR MYXOPAP/WHO I I No No 12 I
7 18/male Dorsal D3-D6 III TR EPEND/WHO II II No Yes 36 I
8 36/male Cervical C2-C5 III STR ASTRO/WHO II III Yes Yes 8 II
9 59/female Dorsal D7-D12 V STR ASTRO/WHO IV IV Yes Yes 4 III
10 55/male Cervical C3-C7 IV TR EPEND/WHO I II No Yes 10 I
11 62/male Cervical C2-C4 IV TR HAEMANGIO/WHO I II No No 36 I
12 53/male Dorsal D1-D5 IV STR HAEMANGIOBLAST/WHO III IV No No 20 III
13 28/male Dorsal D7-D12 II TR EPEND/WHO II II No Yes 12 I
14 69/male Cervical C5-C7 IV TR EPEND/WHO II II No Yes 30 I
15 65/male Cervical C4-C6 II STR EPEND/WHO II II No Yes 15 II
16 65/female Cervical C3-C6 III TR EPEND/WHO I II No Yes 24 I
  1. C cervical, D dorsal, MMS modified McCormick scale score, STR subtotal resection, TR total resection, ASTRO astrocytoma, EPEND ependymoma, MYXOPAP myxopapillary, HAEMANGIO haemangioma, HAEMANGIOBLAST haemangioblastoma, CHEMO chemotherapy, MON month